Pathways and targets how might these affect my treatment decisions gail eckhardt webinar
David Walk
Statistical Issues in Incorporating and Testing Biomarkers in Phase III Clinical Trials FDA/Industry Workshop; September 29, 2006 Daniel Sargent, PhD Sumithra.
Analgesic clinical trials and their assay sensitivity Robert H. Dworkin, PhD Professor of Anesthesiology, Neurology, Oncology, and Psychiatry Professor,
Nicolas PENEL Andrew KRAMAR Centre Oscar Lambret, Lille, France.
Novel Targets and Therapies for GI Malignancies: What does the future hold?
Statistical Issues in Incorporating and Testing Biomarkers in Phase III Clinical Trials
Nicolas PENEL Andrew KRAMAR Centre Oscar Lambret , Lille, France
Critical care 2013, issue 4
